Comparison of intensity-modulated radiotherapy using helical tomotherapy and segmental multileaf collimator-based techniques for nasopharyngeal carcinoma: Dosimetric analysis incorporating quality assurance guidelines from RTOG 0225

Technology in Cancer Research and Treatment

Volumn 9, Issue 3, 2010, Pages 291-298

  Chen, Allen M ^a   Lee, Nancy Y ^b   Yang, Claus C ^d   Liu, Tianxiao ^a   Narayan, Samir ^a   Vijayakumar, Srinivasan ^c   Purdy, James A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF MISSISSIPPI   (United States)

^d NONE

Author keywords

Head and neck cancer; Intensity modulated radiotherapy; Nasopharyngeal carcinoma; Tomotherapy; Treatment planning

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BRAIN STEM; CLINICAL ARTICLE; COLLIMATOR; COMPARATIVE STUDY; DOSIMETRY; HUMAN; INNER EAR; INTENSITY MODULATED RADIATION THERAPY; LARYNX; MIDDLE EAR; MOUTH CAVITY; NASOPHARYNX CARCINOMA; PAROTID GLAND; QUALITY CONTROL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RISK; SEGMENTAL MULTILEAF COLLIMATOR; TOMOTHERAPY; TREATMENT PLANNING; TUMOR;

EID: 77953253673     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303461000900308     Document Type: Article

References (23)

1. Leibel, S. A., Kutcher, G. J., Harrison, L. B., Fass, D. E., Burman, C. M., Hunt, M. A., Mohan, R., Brewster, L. J., Ling, C. C., Fuks, Z. Y. Improved dose distributions for 3D conformal boost treatments in carcinoma of the nasopharynx. Int J Radiat Oncol Biol Phys 20, 823-833 (1991).
2. Wolden, S. L., Zelefsky, M. J., Kraus, D. H., Rosenzweig, K. E., Chong, L. M., Shaha, A. R., Zhang, H., Harrison, L. B., Shah, J. P., Pfister, D. G. Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma. J Clin Oncol 19, 1105-1110 (2001). (Pubitemid 32176287)
3. Perez, C. A., Devineni, V. R., Marcial-Vega, V., Marks, J. E., Simpson, J. R., Kucik, N. Carcinoma of the nasopharynx: Factors affecting prognosis. Int J Radiat Oncol Biol Phys 23, 271-280 (1992).
4. Bauman, G., Yartsev, S., Rodrigues, G., Lewis, C., Venkatesan, V. M., Yu, E., Hammond, A., Perera, F., Ash, R., Dar, A. R., Lock, M., Baily, L., Coad, T., Trenka, K., Warr, B., Kron, T., Battista, J., Van Dyk, J. A prospective evaluation of helical tomotherapy. Int J Radiat Oncol Biol Phys 68, 632-641 (2007).
5. Fiorino, C., Dell'Oca, I., Pierelli, A., Broggi, S., De Martin, E., Di Muzio, N., Longobardi, B., Fazio, F., Calandrino, R. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy. Radiother Oncol 78, 276-282 (2006).
6. Sheng, K., Molloy, J. A., Read, P. W. Intensity-modulated radiation therapy (IMRT) dosimetry of the head and neck: A comparison of treatment plans using linear accelerator-based IMRT and helical tomotherapy. Int J Radiat Oncol Biol Phys 65, 917-923 (2006).
7. Kwong, D. L., Wei, W. I., Sham, J. S., Ho, W. K., Yuen, P. W., Chua, D. T., Au, D. K., Wu, P. M., Choy, D. T. Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment. Int J Radiat Oncol Biol Phys 36, 281-289 (1996).
8. Chen, W. C., Jackson, A., Budnick, A. S., Pfister, D. G., Kraus, D. H., Hunt, M. A., Stambuk, H., Levegrun, S., Wolden, S. L. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma. Cancer 106, 820-829 (2006). (Pubitemid 43238449)
9. Pan, C. C., Eisbruch, A., Lee, J. S., Snorrason, R. M., Ten Haken, R. K., Kileny, P. R. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys 61, 1393-1402 (2005).
10. Honore, H. B., Bentzen, S. M., Moller, K., Grau, C. Sensorineural hearing loss after radiotherapy for nasopharyngeal carcinoma: individualized risk estimation. Radiother Oncol 65, 9-16 (2002).
11. Zuur, C. L., Simis, Y. J., Lamers, E. A., Hart, A. A., Dreschler, W. A., Balm, A. J., Rasch, C. R. Risk factors for hearing loss for patients treated with intensity-modulated radiotherapy for head and neck tumors. Int J Radiat Oncol Biol Phys 74, 490-496 (2009).
12. Ondrey, F. G., Greig, J. R., Herscher, L. Radiation dose to otologic structures during head and neck cancer radiation therapy. Laryngoscope 110, 217-221 (2000). (Pubitemid 30090851)
13. Low, W. K., Toh, S. T., Wee, J., Fook-Chong, S. M., Wang, D. Y. Sensorineural hearing loss after radiotherapy and chemoradiotherapy: a single, blinded, randomized study. J Clin Oncol 24, 1904-1909 (2006). (Pubitemid 46638990)
14. Yeh, S. A., Tang, Y., Lui, C. C., Huang, Y. J., Huang, E. Y. Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int J Radiat Oncol Biol Phys 62, 672-679 (2005).
15. Li, Y., Taylor, J. M., Ten Haken, R. K., Eisbruch, A. The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy. Int J Radiat Oncol Biol Phys 67, 660-669 (2007). (Pubitemid 46215864)
16. Roesink, J. M., Moerland, M. A., Battermann, J. J., Hordijk, G. J., Terhaard, C. H. Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region. Int J Radiat Oncol Biol Phys 51, 928-846 (2001).
17. Jen, Y. M., Hsu, W. L., Chen, C. Y., Hwang, J. M., Chang, L. P., Lin, Y. S., Su, W. F., Chen, C. M., Liu, D. W., Chao, H. L. Different risks of symptomatic brain necrosis in NPC patients treated with different altered fractionated radiotherapy techniques. Int J Radiat Oncol Biol Phys 51, 344-348 (2001).
18. Lee, A. W., Foo, W., Chappell, R., Fowler, J. F., Sze, W. M., Poon, Y. F., Law, S. C., Ng, S. H., O, S. K., Tung, S. Y., Lau, W. H., Ho, J. H. Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 40, 35-42 (1998). (Pubitemid 28027564)
19. Lee, A. W., Kwong, D. L., Leung, S. F., Tung, S. Y., Sze, W. M., Sham, J. S., Teo, P. M., Leung, T. W., Wu, P. M., Chappell, R., Peters, L. J., Fowler, J. F. Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time. Int J Radiat Oncol Biol Phys 53, 75-85 (2002). (Pubitemid 34465809)
20. Sanguineti, G., Endres, E. J., Gunn, B. G., Parker, B. Is there a "mucosa-sparing" benefit of IMRT for head-and-neck cancer? Int J Radiat Oncol Biol Phys 66, 931-938 (2006). (Pubitemid 44436706)
21. Sanguineti, G., Adapala, P., Endres, E. J., Brack, C., Fiorino, C., Sormani, M. P., Parker, B. Dosimetric predictors of laryngeal edema. Int J Radiat Oncol Biol Phys 68, 741-749 (2007).
22. Cheng, K. K., Leung, S. F., Thompson, D. R., Tai, J. W., Liang, R. H., Kan, A. S., Ying, F. W., Yeung, R. M. New measure of health-related quality of life for patients with oropharyngeal mucositis: development and preliminary psychometric evaluation. Cancer 15, 2590-2599 (2007).
23. van Vulpen, M., Field, C., Raaijmakers, C. P., Parliament, M. B., Terhaard, C. H., MacKenzie, M. A., Scrimger, R., Lagendijk, J. J., Fallone, B. G. Comparing step-and-shoot IMRT with dynamic helical tomotherapy IMRT plans for head-and-neck cancer. Int J Radiat Oncol Biol Phys 62, 1535-1539 (2005). (Pubitemid 40982080)